MTOR and nasopharyngeal carcinoma: Upon rapamycin treatment, the induced invasion ability of 5-8F and 6-10B cells by miR-18a was almost completely abrogated (Fig. 4c), indicating that the mTOR pathway mediates the oncogenic role of miR-18a in NPC.